Scarica l'app Stockscreener
0.25
15.17%
-0.0447
Precedente Chiudi:
$0.2947
Aprire:
$0.275
Volume 24 ore:
8.11M
Relative Volume:
0.89
Capitalizzazione di mercato:
$44.59M
Reddito:
-
Utile/perdita netta:
$-12.89M
Rapporto P/E:
-0.0988
EPS:
-2.53
Flusso di cassa netto:
$-11.95M
1 W Prestazione:
-13.40%
1M Prestazione:
-9.16%
6M Prestazione:
-44.11%
1 anno Prestazione:
-66.67%
Intervallo 1D:
$0.243
$0.2762
Intervallo di 1 settimana:
$0.243
$0.328
Portata 52W:
$0.1634
$2.08
Plus Therapeutics Inc Stock (PSTV) Company Profile
Nome
Plus Therapeutics Inc
Settore
Industria
Telefono
737.255.7194
Indirizzo
4200 MARATHON BLVD., AUSTIN, TX
Compare PSTV vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.25 | 44.59M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-03 | Iniziato | Lake Street | Buy |
| 2025-09-03 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2025-03-17 | Iniziato | D. Boral Capital | Buy |
| 2021-01-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-10-16 | Iniziato | Maxim Group | Buy |
Plus Therapeutics Inc Borsa (PSTV) Ultime notizie
Plus: Q4 Earnings Snapshot - theheraldreview.com
Plus Therapeutics (PSTV) Beats EPS Expectations Despite Revenue Decline - GuruFocus
Plus Therapeutics (PSTV) Surpasses Q4 Revenue Expectations - GuruFocus
Plus Therapeutics Reports 2025 Results, Advances CNSide Commercial Rollout and REYOBIQ Clinical Program with 2026 Milestones - Minichart
PLUS THERAPEUTICS, INC. Files Form 8-K with SEC Detailing Shareholder Director Nomination Procedures and Company Information - Minichart
Plus Therapeutics, Inc. 2025 Annual Report: Precision Radiopharmaceuticals and CNS Cancer Innovations - Minichart
Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4 - Yahoo Finance
Plus: Q4 Financial Overview - Bitget
Plus Therapeutics Reports 2025 Results, Business Progress and 2026 Anticipated Milestones for REYOBIQ Clinical Program and CNSide Commercial Rollout - Bitget
Plus Therapeutics 2025 net loss widens - TradingView
Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting - TipRanks
Plus Therapeutics 10-K: $5.21M Grant Revenue, Net Loss $0.29 EPS - TradingView
Plus Therapeutics (NASDAQ: PSTV) updates CNS oncology pipeline and CNSide - Stock Titan
Plus Therapeutics (PSTV) widens 2025 loss but strengthens cash and CNS programs - Stock Titan
Plus Therapeutics Reports 2025 Results, Business Progress and 2026 Anticipated Milestones for REYOBIQ™ Clinical Program and CNSide® Commercial Rollout - The Manila Times
Plus Therapeutics Reports 2025 Results, Business Progress - GlobeNewswire
PSTV Earnings History & Surprises | EPS & Revenue Results | PLUS THERAPEUTICS INC (NASDAQ:PSTV) - ChartMill
Plus Therapeutics drops 5%, files prospectus for 17M share secondary offering - MSN
Can Plus Therapeutics Inc. stock deliver strong Q4 earningsEarnings Miss & Verified Short-Term Trading Plans - Naître et grandir
[RW] PLUS THERAPEUTICS, INC. SEC Filing - Stock Titan
138,897,548 Common Stock of Plus Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-FEB-2026. - marketscreener.com
Certain Warrants of Plus Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-FEB-2026. - marketscreener.com
Certain Restricted Stock Units of Plus Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-FEB-2026. - marketscreener.com
Lake Street Sticks to Their Buy Rating for Plus Therapeutics (PSTV) - The Globe and Mail
Plus Therapeutics (PSTV) CFO granted RSUs and stock options package - Stock Titan
PLUS Therapeutics (PSTV) CEO receives large RSU and stock option grants - Stock Titan
PLUS THERAPEUTICS, Inc.Common Stock (NQ: PSTV - The Chronicle-Journal
PSTV SEC FilingsPlus Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ - Bitget
Plus Therapeutics, Inc. Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ - marketscreener.com
Plus Therapeutics (PSTV) Gains New CPT Code for Innovation in Br - GuruFocus
Plus Therapeutics announces new Category III CPT code - marketscreener.com
Plus Therapeutics Receives AMA Approval for New CPT Code for REYOBIQ in Treatment of CNS Cancers - Quiver Quantitative
Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ™ - GlobeNewswire
PSTV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
New AMA code tracks REYOBIQ therapy in aggressive brain cancers - Stock Titan
Value Recap: Is Plus Therapeutics Inc stock undervalued right nowWeekly Stock Summary & Short-Term Swing Trade Alerts - baoquankhu1.vn
Aug EndMonth: Is Plus Therapeutics Inc stock undervalued right nowMarket Weekly Review & Comprehensive Market Scan Reports - baoquankhu1.vn
Is Plus Therapeutics Inc. in accumulation or distribution phase2025 Retail Activity & Short-Term Trading Opportunity Alerts - mfd.ru
Plus Therapeutics Updates Executive Compensation, Approves 2025 Bonuses - The Globe and Mail
Aug Gainers: Can Plus Therapeutics Inc stock double in the next yearJuly 2025 Drop Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Is Plus Therapeutics Inc. stock showing strong momentumGlobal Markets & Trade Opportunity Analysis - mfd.ru
Can Plus Therapeutics Inc. stock double in the next year2025 Retail Activity & Daily Market Momentum Tracking - mfd.ru
Aug Decliners: Can Plus Therapeutics Inc stock double in the next yearQuarterly Risk Review & Capital Efficient Trading Techniques - baoquankhu1.vn
Aug EndMonth: What is MPWRs valuation compared to sectorStock Surge & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
How Analyst Revisions Are Rewriting The Story For Plus Therapeutics (PSTV) - Yahoo Finance
Merger Talk: What is the dividend yield of Plus Therapeutics IncPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Market Rankings: Is Plus Therapeutics Inc stock undervalued right nowBond Market & Daily Entry Point Alerts - baoquankhu1.vn
Exit Recap: What is Atlas Lithium Corporations revenue forecastJuly 2025 Movers & AI Enhanced Execution Alerts - baoquankhu1.vn
Plus Therapeutics shares climb after subsidiary secures nationwide Humana coverage - MSN
Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial OfferingSlideshow (NASDAQ:PSTV) 2026-01-30 - Seeking Alpha
Plus Therapeutics Inc Azioni (PSTV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):